8101 - 8125 of 8404 Results
Title
Year
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains2010OPENTitle: Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 1Start Page: 27End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23442Best OA location URL: https://europepmc.org/articles/pmc6333467?pdf=renderCitation Count: 164
-
OPENTitle: HCN channelopathy in external globus pallidus neurons in models of Parkinson's diseaseJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 85End Page: 92Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.2692Best OA location URL: https://europepmc.org/articles/pmc3058391?pdf=renderCitation Count: 183
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://europepmc.org/articles/pmc3019295?pdf=renderCitation Count: 41
-
OPENTitle: SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 67Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.279Best OA location URL: https://europepmc.org/articles/pmc3010848?pdf=renderCitation Count: 166
-
OPENTitle: Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progressionJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 570End Page: 580Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22311Best OA location URL: https://europepmc.org/articles/pmc3117674?pdf=renderCitation Count: 404
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
-
OPENTitle: Genetic variation of the mitochondrial complex I subunit NDUFV2 and Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 686End Page: 687Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.09.007Best OA location URL: https://europepmc.org/articles/pmc4381965?pdf=renderCitation Count: 40
- CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s disease2010OPENTitle: CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 118Issue #: 1Start Page: 23End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-010-0485-5Best OA location URL: https://europepmc.org/articles/pmc3090073?pdf=renderCitation Count: 13
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
RESTRICTEDTitle: PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 2Issue #: 52Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3001059Best OA location URL: https://europepmc.org/articles/pmc3129986?pdf=renderCitation Count: 709
-
OPENTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 151
-
RESTRICTEDTitle: Biomarkers in Parkinson’s disease: a funder’s perspectiveJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 723End Page: 729Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.89Citation Count: 17
-
RESTRICTEDTitle: Toxicological and pathophysiological roles of reactive oxygen and nitrogen speciesJournal Name: ToxicologyPublisher: Elsevier BVVol: 276Issue #: 2Start Page: 85End Page: 94Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.tox.2010.07.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237863Citation Count: 181
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
- Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis2010OPENTitle: Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 82Issue #: 5Start Page: 564End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp.2010.222042Best OA location URL: https://europepmc.org/articles/pmc4646086?pdf=renderCitation Count: 100
-
RESTRICTEDTitle: Estimation of Particulate Mass and Manganese Exposure Levels among WeldersJournal Name: The Annals of Occupational HygienePublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/annhyg/meq069Best OA location URL: https://academic.oup.com/annweh/article-pdf/55/1/113/11209915/meq069.pdfCitation Count: 44
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 67
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://europepmc.org/articles/pmc3159957?pdf=renderCitation Count: 81
- Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats2010OPENTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://europepmc.org/articles/pmc3820002?pdf=renderCitation Count: 20
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010OPENTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc3108022?pdf=renderCitation Count: 55
-
OPENTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 83
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010OPENTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 48
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=renderCitation Count: 173
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=renderCitation Count: 64
-
RESTRICTEDTitle: Systemic Weakness After Therapeutic Injections of Botulinum Toxin AJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 33Issue #: 5Start Page: 243End Page: 247Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0b013e3181f5329eBest OA location URL: https://europepmc.org/articles/pmc3563356?pdf=renderCitation Count: 79